Your browser doesn't support javascript.
loading
Interval breast cancer is associated with interferon immune response.
Ugalde-Morales, Emilio; Grassmann, Felix; Humphreys, Keith; Li, Jingmei; Eriksson, Mikael; Tobin, Nicholas P; Lindström, Linda S; Vallon-Christersson, Johan; Borg, Åke; Hall, Per; Czene, Kamila.
Afiliação
  • Ugalde-Morales E; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Electronic address: emilio.ugalde.morales@ki.se.
  • Grassmann F; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Health and Medical University, Potsdam, Germany.
  • Humphreys K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Swedish EScience Research Centre (SeRC), Karolinska Institutet Stockholm, SE-17177, Sweden.
  • Li J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Human Genetics, Genome Institute of Singapore, Singapore, Singapore; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Eriksson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Tobin NP; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Lindström LS; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Vallon-Christersson J; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Medicon Village 404-A2 Lund, SE-22381, Sweden; Lund University Cancer Center Lund, SE-22381, Sweden; CREATE Health Strategic Centre for Translational Cancer Research, Lund University Lund, SE-22381, Sweden.
  • Borg Å; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Medicon Village 404-A2 Lund, SE-22381, Sweden; Lund University Cancer Center Lund, SE-22381, Sweden; CREATE Health Strategic Centre for Translational Cancer Research, Lund University Lund, SE-22381, Sweden; Departm
  • Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Oncology, Södersjukhuset, Stockholm, Sweden.
  • Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Eur J Cancer ; 162: 194-205, 2022 02.
Article em En | MEDLINE | ID: mdl-35026490

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Idioma: En Ano de publicação: 2022 Tipo de documento: Article